MIR4667

Across TCGA pan-cancer cohorts, MIR4667 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR4667’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where MIR4667 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4667 is over-expressed in tumor.

UCEC and COAD are the cancer types where MIR4667 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4667 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	+0.299	.025	2	view →
COAD	All	II,III,IV	+0.174	.046	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MIR4667–UCEC

Open the UCEC breakdown →